Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Infection
Related studies linked through entity extraction aliases.
Single Use ERCP Performance -SURE Study
- Status
- COMPLETED
- Phase
- N/A
Host RNA Signature in Children With Cancer and Infection
- Status
- COMPLETED
- Phase
- N/A
Platelet Rich Plasma and Wound Healing After Cesarean Section
- Status
- COMPLETED
- Phase
- PHASE4
Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2
- Status
- COMPLETED
- Phase
- N/A
Infection With Unknown Origin in the Emergency Department
- Status
- COMPLETED
- Phase
- N/A
Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin
- Status
- TERMINATED
- Phase
- PHASE4
Nurse Leadership for Hospital Infection Control
- Status
- COMPLETED
- Phase
- NA
A Multicentre Pilot Study of Midline Catheter's Tip at a Different Position in Antimicrobial Therapy
- Status
- COMPLETED
- Phase
- NA
Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection
- Status
- RECRUITING
- Phase
- NA
Do Fair Comparisons or Harms Data Increase Responsiveness to Feedback About Antibiotic Prescribing: 2x2 Factorial Trial
- Status
- COMPLETED
- Phase
- NA
Barrier-Protect Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Mannose Binding Lectin Gene Polymorphism Versus Microbial Virulence in the Pathogenesis of Vulvovaginal Candidiasis
- Status
- UNKNOWN
- Phase
- N/A
Pediatric Intensive Care and COVID-19
- Status
- UNKNOWN
- Phase
- N/A
Surgical Management of Medication Related Osteonecrosis of the Jaws With Concentrated Growth Factor
- Status
- COMPLETED
- Phase
- NA
Rural Home Hospital: Proof of Concept
- Status
- COMPLETED
- Phase
- NA
Assocation Between In-person Instruction and COVID-19 Risk
- Status
- COMPLETED
- Phase
- N/A
Recognition of Serious Infections in the Elderly
- Status
- COMPLETED
- Phase
- N/A
Metabolomics and Wound Healing in Diabetes
- Status
- WITHDRAWN
- Phase
- NA
Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
- Status
- WITHDRAWN
- Phase
- PHASE2